Phase I Milestone definition

Phase I Milestone. 5.5.1 “Pre-existing [...***...] Nanobodies” 2.7.1 “Program-Specific Patent Rights” 7.2.4 “Project Liaison” 2.6.4 [...***...] 8.7.4 “Research Materials” 2.10 “Research Program Year 1” 1.91 “Research Program Year 2” 1.91 “Research Program Year 3” 1.91 “Reserved [...***...] Target Combination” 2.12.4 “Royalty Period” 5.6.5 “Safety Termination” 8.3 “Second Product” 5.5.1 “Sensitive Information” 10.2 “Substitute Target” 2.5.1 “Target Addition” 2.5.4
Sample 1Sample 2Sample 3
Phase I Milestone. 5.5.1 “Pre-existing […***…] Nanobodies” 2.7.1
Sample 1Sample 2

Examples of Phase I Milestone in a sentence

  • If (xi) Angiotech is the Discontinuing Party and has elected to decline payment of the Phase I Milestone Fee pursuant to Section 2.4(b), and (xii) Athersys has elected to receive a greater share of Profits pursuant to Section 2.4(b)(ii), then the royalty rate payable to Angiotech pursuant to clause (ii) above shall be [*] percent [*%] and the royalty rate payable to Angiotech pursuant to clause (iii) above shall be [*] percent [*%].

  • All of the members of the Team shall meet during each calendar month of the Phase I Milestone Schedule and the Phase II Milestone Schedule, unless the Parties mutually agree in writing otherwise.

  • While the Phase I Milestone Completion Date is targeted by UTGR to occur at the expiration of six (6) months following the Effective Date, such Phase I Milestone Completion Date shall in any event occur by the first anniversary of the Effective Date, subject, however, to extension as set forth in Section 4.2 or in this Section 4.3 above or in Section 4.3D below.

  • During the Phase I Milestone Schedule, Covad may also deploy or build out XGDSL Service equipment in any CO not included in the Phase I Areas unless such deployment or build out would materially interfere with, slow, or impair Covad’s ability to meet the Phase I Milestone Schedule.

  • The B Warrants will be exercisable for a period equal to the lesser of five years and 30 days after the first press release announcing satisfaction of the Phase I Milestone, but in no circumstances will the B Warrants expire in less than five years if the Phase 1 Milestone is not achieved and reported to the public by March 31, 2012.

  • While the Phase I Milestone Completion Date is targeted by UTGR to occur at the expiration of six (6) months following the Effective Date, such Phase I Milestone Completion Date shall in any event occur by the first anniversary of the Effective Date, subject, however, to extension as set forth in Section 4.2 or in this Section 4.3 above or in Section 4.3 D.

  • If Licensee chooses to proceed, Kineta will be paid, within thirty (30) days of such notification, a milestone payment of $3,500,000 prior to the initiation of such Phase Ib trial (the “Interim Phase I Milestone Payment”).

  • The reduction in profit was largely due to the US$15.0m (AU$15.4m) revenue from GLE for the successful completion of the Test Loop Program Phase I Milestone in the prior year ($nil in the current year).

  • Year ended 30 JuneEPSCentsSTI$Share price at 30 June$2009(2.6)-6.002010(12.3)85,0004.602011(19.6)13,7612.922012(21.6)304,0003.202013(0.1)140,0002.20 The decrease in the negative earnings per share in the current year was mainly due to the US$15.0m (AU$15.4m) revenue from GE- Hitachi Global Laser Enrichment (‘GLE’) for the successful completion of the Test Loop Program Phase I Milestone.

  • The milestones and payment amounts are: Phase I Milestone Dollar Amount T e s t E n v i r o n m e n t E s t a b l i s h e d $ 2 0 , 6 1 3 .

Related to Phase I Milestone

  • Project Milestone means the project milestone set forth in Schedule-J;

  • Development Milestone Event has the meaning set forth in Section 7.2.1.

  • Development Milestone is defined in Section 5.3.

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Project Milestones means the project milestones set forth in Schedule-G;

  • Milestone means an event or task described in the Implementation Plan which must be completed by the corresponding date set out in such plan;

  • Milestone Event has the meaning set forth in Section 8.2.1.

  • Milestone 2 means achievement of annual Net Sales of at least $35,000,000 during any Calendar Year ending on or before December 31, 2024.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Milestone Events has the meaning set forth in Section 7.2.

  • Milestone 1 means achievement of annual Net Sales of at least $20,000,000 during the Calendar Year ending on December 31, 2021.

  • Milestone Dates means the dates for completion of specified Project activities as contained in the Project Schedule.

  • Sales Milestone Payment shall have the meaning set forth in Section 8.4.

  • Performance Milestone means an act or event specified in section 5.1 and described in section 9 of the EPLA.

  • Milestones means control points in the project that help to chart progress. Milestones may correspond to the completion of a key deliverable, allowing the next phase of the work to begin. They may also be needed at intermediary points so that, if problems have arisen, corrective measures can be taken. A milestone may be a critical decision point in the project where, for example, the consortium must decide which of several technologies to adopt for further development.

  • Milestone Schedule means Seller’s milestone schedule, the form of which is attached to this Agreement as Exhibit Q.

  • Milestone Payment has the meaning set forth in Section 4.2.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase I Trial means a Clinical Trial, the principal purpose of which is preliminary determination of safety of an investigational product in healthy individuals or patients or that otherwise meets the requirements described in 21 C.F.R. §312.21(a), or similar Clinical Trial in a country other than the United States.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Milestone Payment Date has the meaning set forth in Section 2.4(a).

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Milestone Notice has the meaning set forth in Section 2.4(a).

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.